Evidence map›Paper›PMID 36148690›Full record

ArticleClinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery2023

Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership.

Carl M Philpott, Andreas Espehana, Mairenn Garden, Ngan Ta, Nishita Gadi, Kala Kumaresan, Devina Maru, Lorenzo D Stafford, Nina Bleasdale, Duncan Boak

Open access · hybridAbstract read
In one paragraph

Article in Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Self-Reported Smell and Taste Disorders in the General Population: A Cross-Sectional Survey in Austria, Germany and Switzerland.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  3. The Need to Promote Olfactory Health in Public Health Agendas Across the Globe.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2026
    Review
  4. Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Carl M PhilpottNorwich Medical School, University of East Anglia, Norwich, UK.ORCID 0000-0002-1125-3236
Andreas EspehanaNorwich Medical School, University of East Anglia, Norwich, UK.ORCID 0000-0003-2872-6826
Mairenn GardenNorwich Medical School, University of East Anglia, Norwich, UK.
Ngan TaNorwich Medical School, University of East Anglia, Norwich, UK.ORCID 0000-0002-8747-5329
Nishita GadiDepartment of Medicine, Anglia Ruskin Univeristy, Chelmsford, UK.
Kala KumaresanNorwich Medical School, University of East Anglia, Norwich, UK.
Devina MaruNational Clinical Champion for Deafness and Hearing Loss, Royal College of General Practitioners, London, UK.
Lorenzo D StaffordDepartment of Psychology, University of Portsmouth, Portsmouth, UK.ORCID 0000-0002-8791-204X
Nina BleasdaleFifth Sense, Barrow-in-Furness, UK.
Duncan BoakFifth Sense, Barrow-in-Furness, UK.
University of East Anglia · GBFurness General Hospital · GBAnglia Ruskin University · GBRoyal National Institute for Deaf People · GBUniversity of Portsmouth · GB

Funding

FifthSense
6 · The paper itself

Abstract

objectivesTo determine the top 10 research priorities in Smell and Taste Disorders (SATD).

designAfter steering group was established, an electronic survey was disseminated to determine the list of questions. After removing out-of-scope responses, the remainder were consolidated to create summary questions. A literature search was conducted to remove already answered questions. A second survey was used to determine the top questions that formed the subject of final debate at a workshop attended by clinicians and patients to determine the top 10 priorities.

settingA James Lind Alliance Priority Setting Partnership (JLAPSP) was established by FifthSense to identify the top 10 research questions in SATDs in the United Kingdom. PARTICIPANT: All stakeholders in SATDs (patients, healthcare professionals, family, carers, researchers).

main outcome measuresFinal 10 research priorities.

resultsThe 665 respondents to the initial survey provided 1698 research questions. Thirteen were out-of-scope and removed; remaining 1685 were then consolidated to form 147 summary questions. Following literature search and discussion with the steering group, 37 questions remained for the second survey, which 235 people responded. The top ten priorities agreed upon in the workshop covered themes of improved understanding of pathophysiologlogy, improving health services, and managing long-term effects of smell/taste disorders. The most important research question agreed was "How can we further our understanding of the mechanism of disease in the nerve pathways that affect smell and taste disorders, including where parosmia and phantosmia exist."

conclusionWe report the top 10 research priorities in smell and taste disorders. These priorities will now empower researchers to secure research funding and provide the basis of the FifthSense research hub.

Indexed as

Biomedical ResearchHealth PrioritiesHumansSmellTaste DisordersUnited Kingdomadvocacyanosmiahyposmiaolfactory disordersparosmiaphantosmia

Identifiers

PMID36148690
PMCPMC10092439
OpenAlexW4296793904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.